Looking for top-rated stocks to buy now? Recent analyst updates highlight three biotech companies that have earned Strong Buy ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage ...

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and ...

The bank's list of highest-conviction stock picks for 2026 spans numerous sectors and features names including Pepsi and GM.

The S&P healthcare index (XLV) saw moderate gains in 2025, reaching a YTD increase of 12.2% by mid-December, though it fell ...

Abivax SA soared about 1,300% after successful trial results for a bowel disease drug, Argenx SE was added to the elite Euro ...

As of Tuesday, December 02, Vir Biotechnology, Inc.’s VIR share price has dipped by 8.57%, which has investors questioning if this is right time to buy.

An investor whose portfolio contains some value- or income-focused investments and some growth-oriented investments, who ...